LifeMD

LifeMD, Inc. is a publicly traded American telehealth company.[3] It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.[4]

History

The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001.[5] In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer.[6] The company changed its name to LifeMD in 2020 and started using the ticker name LFMD.[7][8]

In the first quarter of 2025, LifeMD reported that total revenues increased 49% YoY to $65.7 million.[9]

Services

In September 2022, LifeMD named former Louisiana governor Bobby Jindal to its board of directors.[10]

In June 2023, LifeMD announced a weight management program to prescribe GLP-1 medications upon meeting requirements in a virtual appointment with a clinician.[11] It began a pilot program with Medifast, which later announced a partnership between the companies to connect each other's customers. LifeMD also received a $20 million investment from Medifast at that time.[12]

The company introduced private health insurance acceptance in 2024.[13]

In March 2025, LifeMD signed an agreement to offer Eli Lilly’s weight-loss drug Zepbound to self-paying patients. Specifically, a deal was signed with LillyDirect’s pharmacy partner, through which vials of Zepbound are sold at discounts for cash-pay customers. LifeMD’s stock surged in 2025 after a deal with Novo Nordisk to offer Wegovy through the LifeMD platform at a discounted price.[14]

In April 2025, LifeMD acquired women’s health virtual care provider Optimal Human Health MD, to establish a foundation of hormone health, metabolism, and bone density on its platform.[15]

Further reading

• "Revolutionizing rural healthcare: The untapped power of virtual care" - Washington Examiner